BLANDIZZI, CORRADO
 Distribuzione geografica
Continente #
NA - Nord America 25.043
EU - Europa 10.378
AS - Asia 5.564
AF - Africa 484
SA - Sud America 219
OC - Oceania 44
Continente sconosciuto - Info sul continente non disponibili 12
Totale 41.744
Nazione #
US - Stati Uniti d'America 24.429
IT - Italia 3.743
CN - Cina 2.900
SE - Svezia 2.013
BG - Bulgaria 1.060
SG - Singapore 1.019
DE - Germania 1.005
GB - Regno Unito 634
TR - Turchia 601
CA - Canada 583
UA - Ucraina 520
VN - Vietnam 499
FI - Finlandia 365
CI - Costa d'Avorio 263
RU - Federazione Russa 241
AT - Austria 211
IN - India 193
CH - Svizzera 191
HK - Hong Kong 170
BR - Brasile 161
FR - Francia 141
NG - Nigeria 90
SN - Senegal 87
BE - Belgio 81
AU - Australia 36
PL - Polonia 36
NL - Olanda 32
ID - Indonesia 26
JP - Giappone 24
MX - Messico 24
PK - Pakistan 21
KR - Corea 18
BJ - Benin 16
ES - Italia 16
IQ - Iraq 14
CO - Colombia 13
PT - Portogallo 13
EU - Europa 12
EC - Ecuador 11
IR - Iran 11
CZ - Repubblica Ceca 10
PE - Perù 10
BD - Bangladesh 9
CL - Cile 9
MA - Marocco 9
IE - Irlanda 8
IL - Israele 8
NZ - Nuova Zelanda 8
GR - Grecia 7
RO - Romania 7
AR - Argentina 6
EG - Egitto 6
TW - Taiwan 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
DK - Danimarca 5
LT - Lituania 5
MY - Malesia 5
NO - Norvegia 5
SI - Slovenia 5
UZ - Uzbekistan 5
VE - Venezuela 5
LV - Lettonia 4
PH - Filippine 4
RS - Serbia 4
ZA - Sudafrica 4
ET - Etiopia 3
HR - Croazia 3
HU - Ungheria 3
JO - Giordania 3
MK - Macedonia 3
PY - Paraguay 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
DO - Repubblica Dominicana 2
KZ - Kazakistan 2
LK - Sri Lanka 2
OM - Oman 2
PS - Palestinian Territory 2
TH - Thailandia 2
TN - Tunisia 2
UG - Uganda 2
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CM - Camerun 1
CR - Costa Rica 1
CU - Cuba 1
EE - Estonia 1
HN - Honduras 1
IM - Isola di Man 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
LB - Libano 1
LI - Liechtenstein 1
MN - Mongolia 1
NI - Nicaragua 1
QA - Qatar 1
Totale 41.744
Città #
Woodbridge 3.259
Ann Arbor 2.757
Fairfield 2.362
Houston 2.027
Chandler 1.942
Santa Clara 1.541
Ashburn 1.283
Sofia 1.060
Milan 897
Seattle 893
Shanghai 848
Wilmington 841
Cambridge 806
Serra 792
Beijing 674
Jacksonville 648
New York 607
Singapore 555
Ottawa 534
Boardman 461
Princeton 456
Lawrence 406
Izmir 390
Medford 359
Nanjing 314
Abidjan 263
Des Moines 246
Dong Ket 213
Florence 208
Dearborn 190
Istanbul 182
London 182
Bern 175
Vienna 155
Hong Kong 150
Nanchang 121
Rome 116
Jüchen 113
Redwood City 112
Bremen 107
San Diego 105
Pisa 101
Lagos 89
Dakar 87
Brussels 78
Falls Church 77
Frankfurt am Main 77
Los Angeles 75
Lancaster 70
Kunming 66
Ogden 65
Norwalk 64
Marseille 63
Washington 61
Hebei 59
Shenyang 59
Boulder 56
Tianjin 53
Changsha 50
Chicago 45
Jiaxing 44
Pune 44
Dallas 42
Fuzhou 38
Guangzhou 36
Auburn Hills 35
Düsseldorf 33
Hefei 33
Phoenix 31
Helsinki 29
Toronto 29
Hangzhou 28
Quanzhou 28
Kent 26
Nürnberg 26
Detroit 24
Bologna 23
Jinan 23
Verona 22
Lucca 21
Redmond 21
Orange 19
Warsaw 19
Jakarta 18
Livorno 18
Mumbai 18
Naples 18
San Francisco 18
Wuhan 18
Lanzhou 17
Palermo 17
Turin 17
Cotonou 16
Tappahannock 16
Zhengzhou 16
São Paulo 15
Council Bluffs 14
Hyderabad 14
Montignoso 14
Mountain View 14
Totale 31.597
Nome #
Derivati isoindolici come attivatori di AMPK 398
Different patterns of H2S/NO activity and cross-talk in the control of the coronary vascular bed under normotensive or hypertensive conditions 229
Acute portal vein thrombosis precipitated by indomethacin in a HCV-positive elderly patient 203
An integrated assessment of histopathological changes of the enteric neuromuscular compartment in experimental colitis. 197
Preparation of isoindoline derivatives for use as AMPK activators 194
Exploiting the Pyrazolo[3,4-d]pyrimidin-4-one ring system as a useful template to obtain potent adenosine deaminase inhibitors, 192
Protective Role of Flavonoids Against Colonic Motor Dysfunctions Associated with High Fat Diet-Induced Obesity 190
COMPOSTI INIBITORI DELL’INFLAMMASOMA NLRP3 E LORO USO 189
Derivati benzofuranici come attivatori di AMPK 183
Anti-inflammatory effect of a novel adenosine deaminase inhibitor in experimental colitis 177
Randomised clinical trial: twice daily esomeprazole 40 mg vs. pantoprazole 40 mg in Barrett’s oesophagus for 1 year 170
Alpha-2 adrenoceptors and gastric secretion in dogs: The role of gastrin 167
Periodontal tissue disposition of azithromycin 165
Functional evidence that alpha-2A-adrenoceptors are responsible for anti-lipolysis in human abdominal cells 163
Histochemical Detection of Collagen Fibers by Sirius Red/Fast Green Is More Sensitive than van Gieson or Sirius Red Alone in Normal and Inflamed Rat Colon 163
ROLE OF ENDOTHELIAL NO IN THE VASORELAXING EFFECTS INDUCED BY H2S IN CONDUCTANCE AND RESISTANCE RAT ARTERIES 161
Pathophysiology of NSAID-associated intestinal lesions in the rat: Luminal bacteria and mucosal inflammation as targets for prevention 160
Effect of a novel mucoadhesive polysaccharide obtained from tamarind seeds on the intraocular penetration of gentamicin and ofloxacin in rabbits 159
Alpha-2 adrenoceptors and gastric secretion in dogs: the role of gastrin 158
Effects of suramin on gastric ulceration and EGF content of submandibular glands 158
Quality of adverse drug reaction (QADRA) reports: an algorithm to appraise the efficiency of spontaneous reporting systems in pharmacovigilance 157
A tonic inhibitory control of rat pepsin secretion is mediated by central GABA-A receptors 157
Gabapentin-induced severe myopathy: a case report 156
A2a receptors mediate inhibitory effects of adenosine on colonic motility in the presence of experimental colitis 156
Mast cell neuromuscolar involvement in patients with severe gastrointestinal dysmotility (SGID) 155
Resistance artery mechanics and composition in angiotensin II-infused mice: effects of cyclooxygenase-1 inhibition 155
Safety of MF-59 adjuvanted vaccine for pandemic influenza: results of the vaccination campaign in an Italian health district 153
Adenosine signalling in diabetes mellitus--pathophysiology and therapeutic considerations 153
Gastric mucosal distribution and clinical efficacy of azithromycin in patients with Helicobacter pylori related gastritis 152
Constitutive expression of cyclooxygenase-2 in the neuromuscular compartment of normal human colon 152
Altered expression pattern of molecular factors involved in colonic smooth muscle functions : an immunohistochemical study in patients with diverticular disease 152
Platelet serotonin transporter in patients with diarrhea-predominant irritable bowel syndrome both before and after treatment with alosetron 149
Influence of the serotonin transporter 5HTTLPR polymorphism on symptom severity in irritable bowel syndrome 149
Excitatory and inhibitory cholinergic effects of yohimbine on isolated guinea-pig small intestine 148
Connective remodelling in the colonic neuromuscular compartment of patients with ulcerative colitis 148
Small bowel protection against NSAID-injury in rats: Effect of rifaximin, a poorly absorbed, GI targeted, antibiotic 148
Characterization of a novel mechanism accounting for the adverse cholinergic effects of the anticancer drug irinotecan. 147
Fibrotic and Vascular Remodelling of Colonic Wall in Patients with Active Ulcerative Colitis 147
Endothelial dysfunction in small arteries of essential hypertensive patients: role of cyclooxygenase-2 in oxidative stress generation 147
Immunohistochemical Analysis of Myenteric Ganglia and Interstitial Cells of Cajal in Ulcerative Colitis 146
Clinical efficacy of esomeprazole in the prevention and healing of digestive toxicity associated with non-steroidal anti-inflammatory drugs in elderly patients 145
Targeting enteric neuroplasticity: Diet and bugs as new key factors 144
Overlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndrome 144
Alpha-2A adrenoceptor subtypes modulate cholinergic contractile activity of guinea-pig ileum 143
Enteric alpha-2 adrenoceptors: pathophysiological implications in functional and inflammatory bowel disorders 143
Colonic motor dysfunctions in a mouse model of high-fat diet-induced obesity: an involvement of A2B adenosine receptors 143
Efficay and tolerability of meloxicam, a COX-2 preferential nonsteroidal anti-inflammatory drug: a review 143
Role of a2-adrenoceptors on gastrin release in the dog 142
NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same? 142
Lack of pharmacokinetic bioequivalence between generic and branded amoxicillin formulations. A post-marketing clinical study on healthy volunteers 140
Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration 140
Cholinergic toxic syndrome by the anticancer drug irinotecan: acetylcholinesterase does not play a major role 139
Differential role of cyclooxygenase 1 and 2 isoforms in the modulation of colonic neuromuscular function in experimental inflammation 139
CCK-1 and CCK-2 receptors regulate gastric pepsinogen secretion 139
Enteric protective effects of the combination Bifidobacterium longum and lactoferrin in a rat model of diclofenac-induced intestinal injury. 139
Emerging role of Cyclooxygenase isoforms in the control of gastrointestinal neuromuscular functions 139
Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they? 138
Quinolonecarboxylic acid derivatives as GABA-A receptor antagonists 137
Alteration of endogenous purinergic modulation of tracheal neurotransmission in sensitised guinea-pigs 137
GABA-A-mediated gastrin release induced by baclofen in the isolated vascularly perfused rat stomach 136
Periodontal tissue disposition of azithromycin in patients affected by chronic inflammatory periodontal diseases 135
Comparative pharmacokinetic and pharmacodynamic evaluation of branded and generic formulations of meloxicam in healthy male volunteers 135
A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation 135
Characterization of mechanisms accounting for COX-2-mediated proliferative actions of gastrin on human colon cancer cells 134
Role of cyclooxygenase isoforms in the altered excitatory motor pathways of human colon with diverticular disease 134
Effects of a bicarbonate-alkaline mineral water on gastric functions and functional dyspepsia: a preclinical and clinical study 133
The AMPK enzyme-complex: from the regulation of cellular energy homeostasis to a possible new molecular target in the management of chronic inflammatory disorders 133
Central administration of cholecystokinin stimulates gastric pepsinogen secretion from anaesthetized rats. 133
A selective antimuscarinic agent: pirenzepine. Review of its pharmacologic and clinical properties 132
Neuropsychiatric adverse events associated with statins: epidemiology, pathophysiology, prevention and management 132
Role of Cyclooxygenase isoforms in the neuromodulation of colonic motility in Humans and Mice 131
Effects of esomeprazole on healing of non-steroidal anti-inflammatory drug (NSAID)-induced gastric ulcers in the presence of a continued NSAID treatment: characterization of molecular mechanisms 131
Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders 131
Adverse reactions to oncologic drugs: spontaneous reporting and signal detection 131
The flavonoid compound apigenin prevents colonic inflammation and motor dysfunctions associated with high fat diet-induced obesity 131
VASORELAXING EFFECTS OF H2S IN RAT MESENTERIC ARTERIES 130
The blockade of adenosine deaminase ameliorates chronic experimental colitis through the recruitment of adenosine A2A and A3 receptors 130
Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders 130
Allopurinol adherence among patients with gout: an Italian general practice database study 130
Telogen effluvium following bivalent human papilloma virus vaccine administration: a report of two cases 129
Peripheral 2-hydroxy-saclofen-sensitive GABA-B receptors mediate both vagal-dependent and vagal-independent acid secretory responses in rats 129
Lansoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatory drugs through a reduction of mucosal oxidative damage 129
Cyclooxygenase expression in neuromuscular compartment of normal and inflamed colon 128
Response to Endothelial nitric oxide synthase, cyclooxygenase-2, and essential hypertension: is there an interaction? 128
Adenosine and inflammation: what's new on the horizon? 128
Anti-CD73 in cancer immunotherapy: awakening new opportunities 128
Switching off CD73: a way to boost the activity of conventional and targeted antineoplastic therapies 128
Atrial natriuretic peptide inhibits the spontaneous contractions of isolated rabbit ileum 128
Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients 128
AMP-activated protein kinase as a novel target for the pharmacological treatment of inflammatory bowel diseases 127
A1 and A2a receptors mediate inhibitory rffects of adenosine on the motor activity of human colon 127
Adherence with regulatory resolutions on prevention of NSAIDS-related gastrointestinal injury in Italy 127
Clinical evaluation of piroxicam-FDDF and azithromycin in the prevention of complications associated with impacted lower third molar extraction 126
Transient acute liver failure complicating transurethral resection syndrome 126
Molecular cloning of the canine gastrin/CCK-B receptor gene 125
Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review 125
The pharmacokinetics of ilaprazole for gastro-esophageal reflux treatment 125
Effects of selective cyclooxygenase-2 inhibitors on healing of experimental gastric ulcers and mucosal expression of cyclooxygenase isoforms 124
Involvement of the P2X7 purinergic receptor in colonic motor dysfunction associated with bowel inflammation in rats 124
Enteric dysfunctions in experimental Parkinson's disease: alterations of excitatory cholinergic neurotransmission regulating colonic motility in rats 124
Totale 14.789
Categoria #
all - tutte 123.239
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 123.239


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.023 0 0 0 0 0 0 732 501 666 396 626 102
2020/20213.580 292 152 212 241 328 175 210 293 365 355 213 744
2021/20224.820 115 278 190 359 871 681 144 269 220 158 259 1.276
2022/20236.157 736 833 401 592 682 848 89 457 1.051 42 387 39
2023/20244.461 575 467 549 303 639 774 170 164 70 118 192 440
2024/20254.693 67 509 183 810 1.208 1.356 560 0 0 0 0 0
Totale 42.707